Statins--increasing or reducing the risk of Parkinson's disease?

Exp Neurol. 2011 Mar;228(1):1-4. doi: 10.1016/j.expneurol.2010.11.013. Epub 2010 Nov 24.

Authors

Amalia M Dolga¹, Carsten Culmsee, Lonneke de Lau, Yaroslav Winter, Wolfgang H Oertel, Paul G M Luiten, Ulrich L M Eisel

Affiliation

¹ Institut für Pharmakologie und Klinische Pharmazie, Philipps-Universität Marburg, Germany.

PMID: 21111736
DOI: 10.1016/j.expneurol.2010.11.013

No abstract available

Publication types

Review

MeSH terms

Animals
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Parkinson Disease / drug therapy*
Parkinson Disease / enzymology
Parkinson Disease, Secondary / chemically induced*
Parkinson Disease, Secondary / enzymology
Risk Factors

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors